Filings · News reference

Kala Bio Files ATM Offering Of Up To $250M In Common Stock

Jul 22, 2026, 9:43 PMBenzinga Newsdesk

-SEC Filing

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 3, 2026, 12:32 PMBenzinga Newsdesk
Kala Bio And Virotek Finalizes Definitive Exclusive Distribution And Reseller Agreement And Related Quality, Brand, And Data Protection Agreements
Kala Bio, Inc. (NASDAQ:KALA) ("Kala") and Virotek Inc. ("Virotek") today announced that they have finalized a definitive exclusive distribution and reseller agreement (the "Agreement") and
KALA
BenzingaSep 1, 2026, 2:59 PMBenzinga Newsdesk
KALA BIO shares are trading lower. The company announced it has entered into a letter of intent with Virotek.
KALA
BenzingaSep 1, 2026, 1:39 PMAvi Kapoor
Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ dipped 1.40% to
ALMS BIAF FLYE KALA MDT
BenzingaSep 1, 2026, 11:47 AMBenzinga Newsdesk
Kala Bio Inks Letter Of Intent With Virotek To Discuss Potential Deal To Appoint Kala As Exclusive Distributor, Reseller Of Virotek;s Genetic Testing, Screening Program In U.S. For Ophthalmological Indications
Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the
KALA